BRAF-mutated pleomorphic xanthoastrocytoma is associated with temporal location, reticulin fiber deposition and CD34 expression. (Q53627404)

29 May 2018

title

BRAF-mutated pleomorphic xanthoastrocytoma is associated with temporal location, reticulin fiber deposition and CD34 expression. (English)

1 reference

29 May 2018

Pleomorphic xanthoastrocytoma

main subject

1 reference

2

1 reference

29 May 2018

Matthias Preusser

7

1 reference

29 May 2018

Adelheid Wöhrer

Adelheid Wöhrer

3

0 references

Bernd Romeike

Bernd Romeike

8

0 references

Andreas von Deimling

13

Andreas von Deimling

1 reference

29 May 2018

14

David Capper

1 reference

29 May 2018

5

Jens Schittenhelm

1 reference

29 May 2018

11

Michel Mittelbronn

1 reference

29 May 2018

1

Christian Koelsche

1 reference

29 May 2018

Astrid Jeibmann

4

Astrid Jeibmann

1 reference

29 May 2018

Patricia Kohlhof

6

Patricia Kohlhof

1 reference

29 May 2018

author name string

Hildegard Dohmen-Scheufler

9

1 reference

29 May 2018

Christian Hartmann

10

1 reference

29 May 2018

Albert Becker

12

1 reference

29 May 2018

publication date

29 January 2014

1 reference

29 May 2018

published in

Brain Pathology

1 reference

29 May 2018

volume

24

1 reference

29 May 2018

issue

3

1 reference

29 May 2018

page(s)

221-229

1 reference

29 May 2018

Cerebral pleomorphic xanthoastrocytoma associated with NF1: an updated review with a rare atypical case from Africa.

cites work

1 reference

Exomic sequencing of four rare central nervous system tumor types

21 January 2018

1 reference

The CD34 epitope is expressed in neoplastic and malformative lesions associated with chronic, focal epilepsies.

21 January 2018

1 reference

Detection of the BRAF V600E mutation in serous ovarian tumors: a comparative analysis of immunohistochemistry with a mutation-specific monoclonal antibody and allele-specific PCR.

21 January 2018

1 reference

Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors

21 January 2018

1 reference

Salvage therapy with BRAF inhibitors for recurrent pleomorphic xanthoastrocytoma: a retrospective case series

21 January 2018

1 reference

Dysembryoplastic neuroepithelial tumors share with pleomorphic xanthoastrocytomas and gangliogliomas BRAF(V600E) mutation and expression

21 January 2018

1 reference

Detection of BRAF p.V600E mutations in melanomas: comparison of four methods argues for sequential use of immunohistochemistry and pyrosequencing.

21 January 2018

1 reference

BRAF(V600E) mutation is a negative prognosticator in pediatric ganglioglioma

21 January 2018

1 reference

Expression of CD34 as a novel marker for glioneuronal lesions associated with chronic intractable epilepsy.

21 January 2018

1 reference

BRAF V600E mutations are common in pleomorphic xanthoastrocytoma: diagnostic and therapeutic implications

21 January 2018

1 reference

Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas

21 January 2018

1 reference

Pleomorphic xanthoastrocytoma: what do we really know about it?

21 January 2018

1 reference

Immunophenotype of pleomorphic xanthoastrocytoma.

21 January 2018

1 reference

Pleomorphic xanthoastrocytoma: a comparative pathological study between conventional and anaplastic types.

21 January 2018

1 reference

Immunohistochemistry is highly sensitive and specific for detection of BRAF V600E mutation in pleomorphic xanthoastrocytoma

21 January 2018

1 reference

Pleomorphic xanthoastrocytoma: A distinctive meningocerebral glioma of young subjects with relatively favorable prognosisA study of 12 cases

21 January 2018

1 reference

Epithelioid GBMs show a high percentage of BRAF V600E mutation.

21 January 2018

1 reference

Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGFβ signaling

21 January 2018

1 reference

Mutant BRAF V600E protein in ganglioglioma is predominantly expressed by neuronal tumor cells

21 January 2018

1 reference

Immunohistochemistry is highly sensitive and specific for the detection of V600E BRAF mutation in melanoma.

21 January 2018

1 reference

Primary anaplastic pleomorphic xanthoastrocytoma with widespread neuroaxis dissemination at diagnosis--a pediatric case report and review of the literature

21 January 2018

1 reference

Patterns of care and outcomes of patients with pleomorphic xanthoastrocytoma: a SEER analysis.

21 January 2018

1 reference

BRAF V600E mutation is associated with mTOR signaling activation in glioneuronal tumors

21 January 2018

1 reference

CDKN2A deletion in pediatric versus adult glioblastomas and predictive value of p16 immunohistochemistry.

21 January 2018

1 reference

Comparative histological, histochemical, immunohistochemical and biochemical studies on oestrogen receptors, lectin receptors, and Barr bodies in human breast cancer

21 January 2018

1 reference

The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer

21 January 2018

1 reference

Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomas.

21 January 2018

1 reference

Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma

21 January 2018

1 reference

Anaplastic PXA in adults: case series with clinicopathologic and molecular features

21 January 2018

1 reference

Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma.

21 January 2018

1 reference

CD34 and microtubule-associated protein 2 expression in dysembryoplastic neuroepithelial tumours with an emphasis on dual expression in non-specific types.

21 January 2018

1 reference

Frequent loss of chromosome 9, homozygous CDKN2A/p14(ARF)/CDKN2B deletion and low TSC1 mRNA expression in pleomorphic xanthoastrocytomas.

21 January 2018

1 reference

Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BPA.12111

1 reference

29 May 2018

release_bbyaooxn4vaglkwi33n42fitvm

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bbyaooxn4vaglkwi33n42fitvm

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

24345274

1 reference

29 May 2018